Alterations of gut microbiota diversity, composition and metabonomics in testosterone-induced benign prostatic hyperplasia rats.
Benign prostatic hyperplasia
Gut microbiota
Intestinal metabolites
Microbial diversity
Journal
Military Medical Research
ISSN: 2054-9369
Titre abrégé: Mil Med Res
Pays: England
ID NLM: 101643181
Informations de publication
Date de publication:
28 03 2022
28 03 2022
Historique:
received:
17
09
2021
accepted:
24
02
2022
entrez:
29
3
2022
pubmed:
30
3
2022
medline:
5
4
2022
Statut:
epublish
Résumé
Studies had shown many diseases affect the stability of human microbiota, but how this relates to benign prostatic hyperplasia (BPH) has not been well understood. Hence, this study aimed to investigate the regulation of BPH on gut microbiota composition and metabonomics. We analyzed gut samples from rats with BPH and healthy control rats, the gut microbiota composition and metabonomics were detected by 16S rDNA sequencing and liquid chromatography tandem mass spectrometry (LC-MS/MS). High-throughput sequencing results showed that gut microbiota beta-diversity increased (P < 0.01) in the BPH group vs. control group. Muribaculaceae (P < 0.01), Turicibacteraceae (P < 0.05), Turicibacter (P < 0.01) and Coprococcus (P < 0.01) were significantly decreased in the BPH group, whereas that of Mollicutes (P < 0.05) and Prevotella (P < 0.05) were significantly increased compared with the control group. Despite profound interindividual variability, the levels of several predominant genera were different. In addition, there were no statistically significant differences in several bacteria. BPH group vs. control group: Firmicutes (52.30% vs. 57.29%, P > 0.05), Bacteroidetes (46.54% vs. 41.64%, P > 0.05), Clostridia (50.89% vs. 54.66%, P > 0.05), Ruminococcaceae (25.67% vs. 20.56%, P > 0.05). LC-MS/MS of intestinal contents revealed that differential metabolites were mainly involved in cellular processes, environmental information processing, metabolism and organismal systems. The most important pathways were global and overview maps, lipid metabolism, amino acid metabolism, digestive system and endocrine system. Through enrichment analysis, we found that the differential metabolites were significantly enriched in metabolic pathways, steroid hormone biosynthesis, ovarian steroidogenesis, biosynthesis of unsaturated fatty acids and bile secretion. Pearson correlation analysis (R = 0.94) showed that there was a strong correlation between Prevotellaceae, Corynebacteriaceae, Turicibacteraceae, Bifidobacteriaceae and differential metabolites. Our findings suggested an association between the gut microbiota and BPH, but the causal relationship between the two groups is unclear. Thus, further studies are warranted to elucidate the potential mechanisms and causal relationships between BPH and gut microbiota.
Sections du résumé
BACKGROUND
Studies had shown many diseases affect the stability of human microbiota, but how this relates to benign prostatic hyperplasia (BPH) has not been well understood. Hence, this study aimed to investigate the regulation of BPH on gut microbiota composition and metabonomics.
METHODS
We analyzed gut samples from rats with BPH and healthy control rats, the gut microbiota composition and metabonomics were detected by 16S rDNA sequencing and liquid chromatography tandem mass spectrometry (LC-MS/MS).
RESULTS
High-throughput sequencing results showed that gut microbiota beta-diversity increased (P < 0.01) in the BPH group vs. control group. Muribaculaceae (P < 0.01), Turicibacteraceae (P < 0.05), Turicibacter (P < 0.01) and Coprococcus (P < 0.01) were significantly decreased in the BPH group, whereas that of Mollicutes (P < 0.05) and Prevotella (P < 0.05) were significantly increased compared with the control group. Despite profound interindividual variability, the levels of several predominant genera were different. In addition, there were no statistically significant differences in several bacteria. BPH group vs. control group: Firmicutes (52.30% vs. 57.29%, P > 0.05), Bacteroidetes (46.54% vs. 41.64%, P > 0.05), Clostridia (50.89% vs. 54.66%, P > 0.05), Ruminococcaceae (25.67% vs. 20.56%, P > 0.05). LC-MS/MS of intestinal contents revealed that differential metabolites were mainly involved in cellular processes, environmental information processing, metabolism and organismal systems. The most important pathways were global and overview maps, lipid metabolism, amino acid metabolism, digestive system and endocrine system. Through enrichment analysis, we found that the differential metabolites were significantly enriched in metabolic pathways, steroid hormone biosynthesis, ovarian steroidogenesis, biosynthesis of unsaturated fatty acids and bile secretion. Pearson correlation analysis (R = 0.94) showed that there was a strong correlation between Prevotellaceae, Corynebacteriaceae, Turicibacteraceae, Bifidobacteriaceae and differential metabolites.
CONCLUSION
Our findings suggested an association between the gut microbiota and BPH, but the causal relationship between the two groups is unclear. Thus, further studies are warranted to elucidate the potential mechanisms and causal relationships between BPH and gut microbiota.
Identifiants
pubmed: 35346378
doi: 10.1186/s40779-022-00373-4
pii: 10.1186/s40779-022-00373-4
pmc: PMC8962033
doi:
Substances chimiques
Testosterone
3XMK78S47O
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
12Informations de copyright
© 2022. The Author(s).
Références
Eur Urol. 2012 Mar;61(3):560-70
pubmed: 22119157
Nutrients. 2020 Aug 31;12(9):
pubmed: 32878054
Mil Med Res. 2021 Dec 9;8(1):64
pubmed: 34879880
BJU Int. 2018 Dec;122(6):1049-1065
pubmed: 29694707
Mil Med Res. 2021 Sep 29;8(1):54
pubmed: 34588004
FEBS J. 2020 Mar;287(5):833-855
pubmed: 31955527
Gerontology. 2019;65(5):458-464
pubmed: 30943489
Gut. 2006 Feb;55(2):205-11
pubmed: 16188921
Gut Microbes. 2016 Nov;7(6):533-539
pubmed: 27656762
Nat Rev Microbiol. 2017 Sep;15(9):531-543
pubmed: 28603278
J Urol. 1984 Sep;132(3):474-9
pubmed: 6206240
Cell. 2016 Jan 28;164(3):337-40
pubmed: 26824647
J Int Med Res. 2020 Jun;48(6):300060520931348
pubmed: 32552169
BMC Complement Altern Med. 2019 Oct 17;19(1):270
pubmed: 31623582
Nat Rev Endocrinol. 2020 Dec;16(12):731-739
pubmed: 33106657
Am J Mens Health. 2021 Jul-Aug;15(4):15579883211036786
pubmed: 34330182
Nat Rev Microbiol. 2013 Apr;11(4):227-38
pubmed: 23435359
Brain Behav Immun. 2015 Aug;48:186-94
pubmed: 25882912
Eur Urol. 2017 Oct;72(4):625-631
pubmed: 28434677
Int J Mol Sci. 2017 Dec 07;18(12):
pubmed: 29215589
J Clin Endocrinol Metab. 2018 Apr 1;103(4):1502-1511
pubmed: 29370410
Mol Metab. 2018 Sep;15:70-81
pubmed: 29887245
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3382-3390
pubmed: 31422707
Science. 2018 Nov 16;362(6416):776-780
pubmed: 30442802
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
Philos Trans R Soc Lond B Biol Sci. 2020 Sep 28;375(1808):20190596
pubmed: 32772667
Biomed Pharmacother. 2021 Feb;134:111080
pubmed: 33338744
Front Nutr. 2022 Jan 17;8:815922
pubmed: 35111800
Aging (Albany NY). 2020 Feb 4;12(3):2142-2155
pubmed: 32018227
J Natl Cancer Inst. 2013 Dec 18;105(24):1907-11
pubmed: 24316595
Circ Res. 2015 Jan 30;116(3):448-55
pubmed: 25599331
Antonie Van Leeuwenhoek. 2017 Mar;110(3):445-453
pubmed: 27943013
Nature. 2012 Oct 4;490(7418):55-60
pubmed: 23023125
Front Pharmacol. 2019 Dec 17;10:1425
pubmed: 31920639
Prostate. 2020 Nov;80(15):1341-1352
pubmed: 32835423
Int J Biol Macromol. 2021 Oct 31;189:346-355
pubmed: 34428489
Acta Paediatr Suppl. 1994 Dec;407:86-8
pubmed: 7766968
Annu Rev Med. 2016;67:137-51
pubmed: 26331999
Aging (Albany NY). 2021 Apr 13;13(8):10934-10954
pubmed: 33847600
Crit Rev Eukaryot Gene Expr. 2018;28(2):115-124
pubmed: 30055537
Nat Rev Dis Primers. 2016 May 05;2:16031
pubmed: 27147135
Int J Environ Res Public Health. 2021 Aug 11;18(16):
pubmed: 34444249
Genome Biol. 2011 Jun 24;12(6):R60
pubmed: 21702898
J Lipid Res. 2013 Sep;54(9):2437-49
pubmed: 23772041
Med Res Rev. 2021 May;41(3):1812-1834
pubmed: 33377531
Front Microbiol. 2017 Feb 28;8:324
pubmed: 28293234
Liver Int. 2012 Oct;32(9):1363-71
pubmed: 22845860
Mar Drugs. 2019 Jun 22;17(6):
pubmed: 31234533
ISME J. 2011 Feb;5(2):169-72
pubmed: 20827291
Sci Rep. 2017 Nov 13;7(1):15428
pubmed: 29133842
Gut Microbes. 2017 Jul 4;8(4):359-365
pubmed: 28112583
Front Physiol. 2019 Jul 23;10:918
pubmed: 31396097
Front Cell Dev Biol. 2021 Jun 24;9:615928
pubmed: 34249898
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
Aging Male. 2020 Dec;23(5):655-662
pubmed: 30739562
Mil Med Res. 2019 Nov 13;6(1):34
pubmed: 31718713
Curr Neurol Neurosci Rep. 2018 Jun 28;18(8):54
pubmed: 29956001
Prostate. 2021 Dec;81(16):1287-1293
pubmed: 34516694
Genes Dev. 2016 Jul 15;30(14):1589-97
pubmed: 27474437
PLoS One. 2010 Feb 05;5(2):e9085
pubmed: 20140211
Microbiome. 2019 Feb 19;7(1):28
pubmed: 30782206
Front Microbiol. 2020 Jan 21;10:3145
pubmed: 32038578
Dev Comp Immunol. 2020 Jan;102:103470
pubmed: 31430486